MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/jso.70415

Медицинская библиотека · Journal of surgical oncology · 2026

Hepatic Adenomas in Men: Diagnostic Considerations and Management in the Modern Era.

Belledent Teresa, Nwosu Julie, Brevik Kiers, Abbey Raegen M, Pawlik Timothy, Hwang Dae Sun, Hayes Terry L, Nwosu Ikenna, Suraju Mohammed O, Aziz Hassan

СтатьяОбзорПеревод пока не подготовлен

Аннотация

Hepatic adenomas (HAs) are rare benign liver tumors traditionally associated with young women, yet contemporary epidemiologic trends reveal increasing recognition among men. Historically, universal resection in males has been recommended because of a nearly tenfold increased risk of malignant transformation as reported by Farges et al. in a single-institution surgical series; however, advances in molecular profiling and imaging have challenged this paradigm. β-catenin-activated and inflammatory subtypes account for most cases in men, often associated with anabolic steroid exposure, obesity, or metabolic syndrome. β-catenin-activated adenomas-particularly those harboring CTNNB1 exon 3 mutations-demonstrate the strongest correlation with malignant potential. Magnetic resonance imaging with hepatobiliary contrast agents can suggest subtype but lacks perfect accuracy; biopsy offers improved diagnostic precision and enables molecular confirmation. Current ACG and EASL guidelines still endorse routine resection for all hepatic adenomas in males; however, available retrospective data suggest that malignant transformation appears to be uncommon in small (5 cm) lesions lacking exon 3 CTNNB1 mutations; however, this observation is derived from limited, predominantly retrospective data and does not exclude the possibility of malignant transformation in this subgroup. These data support selective, biopsy-guided surveillance for small, indeterminate tumors within experienced multidisciplinary centers where longitudinal follow-up is reliable. Resection remains the standard recommendation for large or β-catenin-mutated adenomas, with minimally invasive surgery demonstrating excellent outcomes. Modern management of hepatic adenomas in men should be individualized, integrating molecular subtype, size, risk factors, and patient context. A multidisciplinary and molecularly informed strategy is essential to optimize outcomes while avoiding unnecessary intervention.

Для цитирования: Belledent Teresa, Nwosu Julie, Brevik Kiers, Abbey Raegen M, Pawlik Timothy, Hwang Dae Sun, Hayes Terry L, Nwosu Ikenna, Suraju Mohammed O, Aziz Hassan. Hepatic Adenomas in Men: Diagnostic Considerations and Management in the Modern Era.. Journal of surgical oncology. 2026. DOI: 10.1002/jso.70415.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.